20 Years of Automated Cell Culture - Cell Culture 'Future'

TAP - 20 Years of Automated Cell Culture - 1989 - 2009

Leading industry figures provide their insights into the next twenty years of research, development and commercialisation of regenerative medicine and cell therapies and how the business landcape may look in the future.

Professor David Williams discusses the development of regenerative medicine over the next twenty years and the challenges the industry will face to become fully commercialised.

TAP CEO David Newble shares his vision of how TAP is ideally positioned to take advantage of future trends in drug discovery and manufacture.


Professor David Williams is the latest episode in the TAP Cell Culture podcast series.
Subscribe to the '20 years of automated cell culture' podcast for interviews, presentations and news.

For more information on TAP or our '20 Years of Automated Cell Culture', please contact us